Tekla Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Tekla Capital Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-41,980	Closed	-$746K	–	219
2018 Q3	$746K	Buy	+41,980	New	+$721K	0.03%	188
2013 Q3	–	Sell	-60,200	Closed	-$790K	–	66
2013 Q2	$790K	Buy	+60,200	New	+$812K	0.11%	57

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Tekla Capital Management's ECYT Position: Q4 2018 in Review

Tekla Capital Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 41,980 shares — an estimated $746K sold.

Tekla Capital Management first reported a position in ECYT in Q2 2013 and held it in 2 quarters. The position peaked at $790K in Q2 2013. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Tekla Capital Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Tekla Capital Management sold 41,980 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $746K.
Tekla Capital Management first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
Tekla Capital Management's Endocyte, Inc. Common Stock position peaked at $790K in Q2 2013.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Tekla Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.